维普中文期刊产品整合服务
13篇 您的检索式:作者名="Masier"
    题名 作者 年代 出处 被引量
1Dynamic tests to study liver function显示文摘Burra P Masier A 2004Eur Rev Med Pharmacol Sci2004,8,1:1
2UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicity显示文摘Biason P Masier S Toffoli G 0,,02:1
3UGTIA1^* 28 and other UGT1A polymorphisms as determinants of irinotecan toxicity显示文摘Biason P Masier S Toffoli G 2008J Chemother2008,20,2:1
4Dynamic tests to study liver function显示文摘Burra P Masier A 2004E- ur Rev Med Pharmacol Sci2004,8,1:1
5Dynamic tests to study liver function显示文摘Burra P Masier A 2004Eur Rev Med Pharmacol Sci2004,8,1:1
6Dynamic tests to study liver function显示文摘Burra P Masier A 2004Eur Rev Med Pharmacol Sci2004,8,1:1
7Carboxylesterase isoform 2 mRNA expression in peripheral blood mononuelear cells is a predictive marker of the irinotecan to SN38 activa- tion step in colorectal cancer patients 显示文摘Cecehin E Corona G Masier S 2005Clin Cancer Res2005,11,191:1
8Factors influencing renal function after liver transplantation, results from the MOST, an international observational study 显示文摘Burra P Senzolo M Masier A 2009Dig Liver Dis2009,41,5:1
9Is podocyte injury relevant in diabetic nephropathy?Studies in patients with type 2 diabetes显示文摘 Masier A Roiter AM 2003Diabetes2003,52,4:1
10Dynamic tests to study liver function显示文摘 Masier A 2004Eur Rev Med Phannacol Sci2004,8,1:1
11Dynamic tests to study liver function显示文摘Burra P Masier A 2004Eur Rev Med Pharmacol Sci2004,8,1:1
12HCV infection in haemodialysed patients: A role for serum IL-10 and TGF-β1 in liver damage 显示文摘Burra P Masier A Morisco F 2008Digestive and Liver Disease2008,40,10:1
13UGT1A1*28 and other UGT1A polymorphisms as determinants of irinotecan toxicity显示文摘Biason P Masier S Toffoli G 0,,02:1
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费